Varda Space Industries
| Company type | Private |
|---|---|
| Industry | Space research, Space manufacturing |
| Founded | January 2021 |
| Founder | Will Bruey, Delian Asparouhov |
| Headquarters | El Segundo , United States |
Area served | Space manufacturing |
Key people | Will Bruey, Delian Asparouhov |
| Products | Spacecraft for pharmaceutical manufacturing in microgravity, W-Series re-entry capsules |
| Owner | Private investors including Khosla Ventures and Founders Fund |
| Website | vardaspace |
Varda Space Industries, Inc is a private American company specializing in space research, headquartered in El Segundo, California. Established in January 2021 by Will Bruey and Delian Asparouhov, the firm focuses on creating spacecraft designed to manufacture pharmaceuticals within the unique environment of microgravity. Its core expertise lies in crystallizing small molecules, a process challenging to replicate under Earth's gravitational conditions, with products brought back through atmospheric reentry capsules. Key investors include Khosla Ventures and Founders Fund.
History
Varda was initiated by former SpaceX engineer Will Bruey alongside Founders Fund partner Delian Asparouhov. Since 2021, the company has been developing spacecraft aimed at producing materials such as pharmaceuticals, fiber optics, and semiconductors in contamination-free microgravity. Following an initial $9 million capital injection in December 2020, Varda secured $42 million in funding by July 2021 and subsequently raised $90 million in April 2024.
In August 2021, Varda engaged Rocket Lab to supply three Photon satellite buses, with the first unit delivered during the second quarter of 2023. By October 2021, SpaceX was chosen to conduct the company’s initial four launches. The inaugural 300 kg spacecraft was deployed aboard Falcon 9’s Transporter-8 mission in June 2023 to validate pharmaceutical manufacturing capabilities in orbit. The return capsule was scheduled for Earth reentry around mid-August 2023.
The launch proceeded with FAA authorization contingent upon obtaining a reentry license prior to capsule return. However, a planned reentry on September 6, 2023 was denied due to regulatory issues involving the FAA and the designated landing site. As a result, Varda evaluated alternative reentry locations, including Australia's Koonibba Test Range. Eventually, on February 14, 2024, the FAA approved the reentry license, allowing the Winnebago-1 capsule to successfully return on February 21, 2024.
Facilities
Varda maintains offices in both Washington, D.C., and El Segundo, California. The El Segundo site is responsible for manufacturing vehicles, equipment, and materials as well as their integration and testing. This headquarters also houses a pharmaceutical laboratory alongside a hypergravity crystallization platform utilized for screening small-molecule drug crystallization processes.
W-Series re-entry capsule
The W-Series capsules are autonomous platforms engineered for producing formulations in microgravity and designed for safe terrestrial recovery. These capsules reenter Earth's atmosphere at velocities exceeding Mach 25 (more than 30,000 km/h) and descend under parachute deployment. Their heat shields are made from C-PICA (Conformal Phenolic Impregnated Carbon Ablator), a thermal protection material developed by NASA Ames Research Center. The W-1 mission represented the first space return using a C-PICA heat shield manufactured by NASA. Varda became the pioneer company awarded a special FAA Part 450 vehicle operator license for the W-4 mission, enabling multiple reentries without submitting safety documentation for each flight; this license remains valid through 2029.
W-1
The W-1 capsule achieved several milestones as the first commercial spacecraft to land on a U.S. military test range and the first to perform atmospheric reentry under FAA Part 450 regulations. It successfully demonstrated onboard pharmaceutical production by growing crystals of Form III of ritonavir, an antiretroviral medication.
W-2
Varda's W-2 capsule was deployed in January 2025 as part of SpaceX's Transporter-12 rideshare mission, carrying payloads from both the Air Force Research Laboratory and NASA. Among its instruments was the Optical Sensing of Plasmas in the ReEntry Environment (OSPREE) experiment, which utilized optical emission spectroscopy (OES) to perform direct measurements of the shock layer during atmospheric reentry. On February 28, 2025, Varda achieved a successful recovery of the capsule at the Koonibba Test Range in South Australia, securing vital data that supports advancements in space-based manufacturing and hypersonic technology development. The OSPREE payload obtained detailed radiative emission spectra from the shock layer, delivering unprecedented spectroscopic information on reentry thermochemistry that had not been documented in prior research.
W-3
The W-3 capsule was launched on March 14, 2025, aboard SpaceX's Transporter-13 rideshare mission and completed reentry on May 14, 2025, at the Koonibba Test Range. This event represented Varda’s third successful orbital capsule retrieval.
W-4
On June 24, 2025, Varda launched its W-4 capsule via SpaceX's Transporter-14 rideshare mission. This mission introduced the company’s inaugural use of a proprietary spacecraft bus, marking a strategic advancement toward improved operational control and scalability within their space manufacturing initiatives.